Perioperative management of von Willebrand patients at the time of implant placement: Case report

Clin Case Rep. 2021 Aug 30;9(9):e04755. doi: 10.1002/ccr3.4755. eCollection 2021 Sep.

Abstract

In the management of patients with type 1 von Willebrand disease, supplementation with Con Facto F® as well as hemodynamic stabilization with appropriate analgesia and sedation may be important to reduce the risk of bleeding.

Keywords: a hemostatic factor; factor VIII concentrate (Confact F®); von Willebrand disease.

Publication types

  • Case Reports